-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Ixei/XhvLHW1mALoFA7A3kkfNV/hpLp31UuHVZTB99d+KQlTLIF7EleWbGOImZDd 6YiWSXlXP742/avo6Ckr0g== 0001104659-06-022274.txt : 20060404 0001104659-06-022274.hdr.sgml : 20060404 20060404213346 ACCESSION NUMBER: 0001104659-06-022274 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20060401 FILED AS OF DATE: 20060404 DATE AS OF CHANGE: 20060404 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ABGENIX INC CENTRAL INDEX KEY: 0001052837 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 943248826 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6701 KAISER DRIVE CITY: FREMONT STATE: CA ZIP: 94555 BUSINESS PHONE: 5106086500 MAIL ADDRESS: STREET 1: 6701 KAISER DRIVE CITY: FREMONT STATE: CA ZIP: 94555 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Joseph Donald CENTRAL INDEX KEY: 0001319460 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-24207 FILM NUMBER: 06740349 BUSINESS ADDRESS: BUSINESS PHONE: 510-608-6500 MAIL ADDRESS: STREET 1: 6701 KAISER DRIVE CITY: FREMONT STATE: CA ZIP: 94555 4 1 a4.xml 4 X0202 4 2006-04-01 1 0001052837 ABGENIX INC ABGX 0001319460 Joseph Donald 6701 KAISER DRIVE FREMONT CA 94555 0 1 0 0 Senior VP, Gen. Counsel & Sec. Common Stock, par value $0.0001 per share 2006-04-01 4 D 0 939 22.50 D 0 D Non-Qualified Stock Option (right to buy) 8.16 2006-04-01 4 D 0 150000 D 2005-03-10 2012-03-10 Common Stock, par value $0.0001 per share 150000 0 D The total shares subject to the option became fully exercisable on 4/1/2006. This option was converted into an option to acquire 46,500 shares of Amgen Inc. common stock at an exercise price of $26.33 per share pursuant to the terms of the Agreement and Plan of Merger, dated as of December 14, 2005, among Abgenix, Inc., Amgen Inc. and Athletics Merger Sub, Inc. /s/ George F. Fraley (Attorney-in-Fact) 2006-04-01 -----END PRIVACY-ENHANCED MESSAGE-----